Although it is too early to assess whether secondary RNAi pathways could be exploited as new tools for manipulating gene expression for biotechnology, the elucidation of these pathways should ...

Several RNAi-based therapies are currently in clinical trials, and some have already been approved for clinical use. RNAi has applications in agriculture and biotechnology, such as developing ...